Cefotiam
General information:
| Withdrawn ID: | 1045 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | J01DC07 |
| Molecular Formula: | C18H23N9O4S3 |
| Molweight: | 525.628 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|---|
| First approved: | 1988 |
Side-effects:
| Total reported cases (submitted by medical professionals) with Cefotiam as primary suspect: | 3 |
|---|
Reported final outcomes:
| Hospitalization (initial or prolonged): | 3 |
|---|---|
| Death: | 1 |
Reported side-effects:
| Side-effect | Case number |
|---|---|
| DRUG INTERACTION | 2 |
| PSEUDOMEMBRANOUS COLITIS | 1 |
| INTERNATIONAL NORMALISED RATIO INCREASED | 1 |
| HEPATIC FUNCTION ABNORMAL | 1 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 1 |
| DIARRHOEA | 1 |
| CLOSTRIDIUM DIFFICILE COLITIS | 1 |
| ANAL HAEMORRHAGE | 1 |
Toxicity information:
| Toxicity class: | 5 |
|---|---|
| Toxicity type: | N/A |
| LD50: | 3000 mg/kg |
External links:
| ChEBML: | CHEMBL1296 |
|---|---|
| DrugBank: | DB00229 |